Urea, N-phenyl-N'-[(3S)-2,3,4,5-tetrahydro-2,4-dioxo-1-phenyl-5-(tricyclo[3.3.1.13,7]dec-1-ylmethyl)-1H-1,5-benzodiazepin-3-yl]-;(S)-1-(1-(adamantan-1-ylmethyl)-2,4-dioxo-5-phenyl-2,3,4,5-tetrahydro-1H-benzo[b][1,4]diazepin-3-yl)-3-phenylurea;GV-150013X, 10 mM in DMSO
GV-150013X is a cholecystokinin-2/gastrin receptor (CCK2R) antagonist with a Ki of 2.29 nM; it is used to alleviate anxiety, panic disorders, and related central nervous system disorders.